MedDataX Logo

Comparative Assessment of Viscosupplementation With Polynucleotides and Hyaluronic Acid

NCT02417610 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 102

Last updated 2017-12-26

No results posted yet for this study

Summary

The purpose of the study is to assess the validity of the polynucleotide within the intra articular treatment of osteoarthritis of the knee, comparing it with that of hyaluronic acid, the most commonly used.

Conditions

  • Osteoarthritis

Interventions

DEVICE

Polynucleotide - PNHA - Newart

gel polynucleotides and hyaluronic acid

DEVICE

Hyaluronic acid - HA - Ialart

Hyaluronic acid

Sponsors & Collaborators

  • Istituto Ortopedico Rizzoli

    lead OTHER

Principal Investigators

  • Dante Dallari, MD · Istituto Ortopedico Rizzoli

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2017-07-31
Completion
2017-07-20

Countries

  • Italy

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02417610 on ClinicalTrials.gov